Versor Investments LP Has $1.29 Million Position in Option Care Health, Inc. $OPCH

Versor Investments LP reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 30.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,564 shares of the company’s stock after selling 17,336 shares during the period. Versor Investments LP’s holdings in Option Care Health were worth $1,285,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. USA Financial Formulas acquired a new stake in Option Care Health during the 2nd quarter worth approximately $26,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares during the last quarter. Brooklyn Investment Group increased its stake in Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after acquiring an additional 780 shares during the period. Wealthquest Corp bought a new position in Option Care Health during the 1st quarter worth $66,000. Finally, Nisa Investment Advisors LLC increased its stake in Option Care Health by 80.0% during the 1st quarter. Nisa Investment Advisors LLC now owns 3,066 shares of the company’s stock worth $107,000 after acquiring an additional 1,363 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

OPCH has been the topic of a number of recent research reports. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Friday. Morgan Stanley initiated coverage on Option Care Health in a research note on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective on the stock. Citizens Jmp lowered their price objective on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research note on Friday. Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research note on Friday. Finally, TD Cowen initiated coverage on Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating and a $30.00 price objective on the stock. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $35.10.

Insider Activity

In other Option Care Health news, Director Norman L. Wright purchased 3,411 shares of the firm’s stock in a transaction dated Tuesday, September 9th. The shares were bought at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This trade represents a 28.21% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 20th. The shares were purchased at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. The trade was a 10.61% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have acquired 59,411 shares of company stock worth $1,627,576. Insiders own 0.64% of the company’s stock.

Option Care Health Trading Down 0.6%

Shares of OPCH opened at $26.03 on Friday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The business’s fifty day moving average is $27.92 and its 200-day moving average is $29.89. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a market cap of $4.22 billion, a price-to-earnings ratio of 20.82, a PEG ratio of 1.74 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the company posted $0.41 EPS. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.680-1.720 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.